News
New Ellansé™ publication in Eur. J. Aesth. Medicine and Dermatology
Preliminary results in using a new dermal filler based on poly-caprolactone
Over the last decades, the minimal-invasive aesthetic medicine dramatically increased. Nowadays, patients are looking more often for aesthetic improvements without, or with a very low rate, of complications and days off work. One of the most performed, and required, procedures in aesthetic medicine are dermal fillers. In the last twenty years many permanent, semi-permanent and non-permanent fillers have been introduced in this field. The author discusses his experience in using a new dermal filler based on poly-caprolactone
Read the full story here!
Preliminary results in using a new dermal filler based on poly-caprolactone
Over the last decades, the minimal-invasive aesthetic medicine dramatically increased. Nowadays, patients are looking more often for aesthetic improvements without, or with a very low rate, of complications and days off work. One of the most performed, and required, procedures in aesthetic medicine are dermal fillers. In the last twenty years many permanent, semi-permanent and non-permanent fillers have been introduced in this field. The author discusses his experience in using a new dermal filler based on poly-caprolactone
Read the full story here!
ELLANSÉ™, winner of the 2011 Frost & Sullivan Technology Innovation Award
ELLANSÉ™, winner of the Frost & Sullivan 2011 European Technology Innovation of the Year Award in Dermal Fillers!
Read the full story here!
ELLANSÉ™, winner of the Frost & Sullivan 2011 European Technology Innovation of the Year Award in Dermal Fillers!
Read the full story here!
Press Releases 2011
Press Releases 2012
- Ellansé™ ‘Dermal Filler Innovation of the Year’.
- Ellansé™ dermal filler Family gained market approval for Australia.
Press Releases 2012